Urgent.News

600+ sources. One page. See who else covered it.

Editions

Science

A new ADHD drug targets three brain chemicals instead of two. Here's what that means

A new medicine for attention-deficit/hyperactivity disorder (ADHD) has just entered the treatment toolbox: centanafadine, a once-daily tablet sold under the brand name Simtriyo.

A new ADHD drug targets three brain chemicals instead of two. Here's what that means

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at medicalxpress.com →

More in Science

More from Thursday 13 August →